Axulta, Kapseln

7680654020017 CH-65402 A06AX04 04.08.11

Active substances:

No images available

Details

Product number
6540201
CPT
-
Packaging group
7
Unit
Kapsel(n)
Composition
Kapsel: linaclotidum 0.29 mg, cellulosum microcristallinum, hypromellosum, calcii chloridum dihydricum, leucinum, Kapselhülle: gelatina, E 171, E 172 (rubrum), E 172 (flavum), propylenglycolum, kalii hydroxidum, lacca, ammoniae solutio concentrata, E 172 (nigrum) pro capsula.

Articles (1)

Axulta, Kapseln
Kapseln
7
View

Official Swissmedic V2 data

Additional information from the official database

Detailed composition

Substance Quantity Type Category
linaclotidum
0.29 MG Substance Wirkstoff (Principe actif)
cellulosum microcristallinum
- Substance HNIDK
hypromellosum
- Substance HNIDK
calcii chloridum dihydricum
- Substance HNIDK
leucinum
- Substance HNIDK
gelatina
- Substance HNIDK
E 171
- Substance FNIDK
E 172 (rubrum)
- Substance FTODK
E 172 (flavum)
- Substance FTODK
propylenglycolum
- Substance HNIDK
kalii hydroxidum
- Substance HNIDK
lacca
- Substance HNIDK
ammoniae solutio concentrata
- Substance HNIDK
E 172 (nigrum)
- Substance FTODK

Authorization holder

AstraZeneca AG

6340 Baar

Authorization information

Swissmedic authorization number
65402
Drug name
Axulta, Kapseln
Galenic form
KAHA
ATC Code
A06AX04
Authorization status
Z
Dispensation category
B
First authorization
24/03/2015
Authorization expiration date
31/12/9999
IT number
04.08.11
Domain
Human medicine
Field of application
Symptomatische Behandlung von moderatem bis schwerem Reizkolon-Syndrom mit Obstipation bei Erwachsenen

Packaging details

Description (FR)
AXULTA caps 0.29 mg 7 pce
Description (DE)
AXULTA Kaps 0.29 mg 7 Stk
Narcotic (BTM)
No

Other packaging sizes

Buy us a coffee Explore the data